Section 22-B599. DEFINITIONS

 

599.1As used in this chapter the following terms shall have the meanings ascribed:

 

Act - District of Columbia Unused Pharmaceutical Safe Disposal Act of 2009, effective March 5, 2010 (D.C. Law 18-112, D.C. Official Code §§ 48-851.01, et seq. (2012 Repl.))

 

Board - District of Columbia Board of Pharmacy

 

Department - Department of Health

 

Director - Director of the Department

 

Hazardous pharmaceutical waste - a pharmaceutical product that is defined as hazardous waste under federal or District law.

 

Health care facility – a hospital, assisted living facility, nursing home, or institutional pharmacy.

 

Institutional pharmacy – that physical portion of a health care facility where drugs, devices, and other materials used in the diagnosis or treatment of injury, illness, and disease are dispensed, compounded, or distributed and pharmaceutical care is provided.

 

Pharmaceutical product – a drug or biologic for human use regulated by the federal Food and Drug Administration.

 

Pharmaceutical waste - a pharmaceutical product that is no longer suitable for its intended purpose or is otherwise being discarded, but does not include pharmaceuticals excreted from the body during normal physiological functions and medical procedures.

 

Pharmaceutical waste minimization program - a program used to identify pharmaceuticals that need to be discarded, to decrease pharmaceutical waste, and to implement more environmentally sustainable practices regarding pharmaceutical waste disposal.

 

authority

Sections 4 and 5 of the District of Columbia Unused Pharmaceutical Safe Disposal Act of 2009, (the Act), effective March 5, 2010 (D.C. Law 18-112, D.C. Official Code §§ 48-851.03 and 48-851.04 (2012 Repl.)) and Mayor’s Order 2011-90, dated May 6, 2011.

source

Final Rulemaking published at 60 DCR 9354 (June 21, 2013).